The role of P-glycoprotein/cellular prion protein interaction in multidrug-resistant breast cancer cells treated with paclitaxel

Cellular and Molecular Life Sciences

Volumn 66, Issue 3, 2009, Pages 504-515

  Li, Q Q ^a   Cao, X X ^a   Xu, J D ^a   Chen, Q ^a   Wang, W J ^a   Tang, F ^b   Chen, Z Q ^b   Liu, X P ^a   Xu, Z D ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Caveolin 1; CD147; EGFR; In vitro invasion; P glycoprotein; Paclitaxel; PrPc

Indexed keywords

CASPASE; CAVEOLIN 1; GLYCOPROTEIN P; PACLITAXEL; PRION PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CAVEOLA; CELL INVASION; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG BINDING; DRUG INHIBITION; DRUG MECHANISM; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MULTIDRUG RESISTANCE; PLASMID; PROTEIN DEPLETION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CAVEOLAE; CAVEOLIN 1; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; P-GLYCOPROTEIN; PACLITAXEL; PRPC PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 59349095913     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8548-6     Document Type: Article

References (38)

1. Hennequin, E., Delvincourt, C., Pourny, C. and Jardillier, J. C. (1993) Expression of mdr1 gene in human breast primary tumors and metastases. Breast Cancer Res. Treat. 26, 267-274
2. Isonishi, S., Hom, D. K., Thiebaut, F. B., Mann, S. C., Andrews, P. A., Basu, A., Lazo, J. S., Eastman, A. and Howell, S. B. (1991) Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin. Cancer Res. 51, 5903-5909
3. Yang, J. M., Xu, Z. D., Wu, H., Zhu, H. G., Wu, X. H. and Hait, W. N. (2003) Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistance cancer cell. Mol. Cancer Res. 1, 420-427
4. Li, Q. Q., Wang, W. J., Xu, J. D., Cao, X. X., Chen, Q., Yang, J. M. and Xu, Z. D. (2007) Up-regulation of CD147 and matrix metalloproteinase-2, -9 induced by P-glycoprotein substrates in multidrug resistant breast cancer cells. Cancer Sci. 98, 1767-1774
5. Yang, J. M., Vassil, A. and Hait, W. N. (2002) Involvement of phosphatidylinositol-3-kinase in membrane ruffling induced by P-glycoprotein substrates in multidrug-resistant carcinoma cells. Biochem. Pharmacol. 63, 959-966
6. Endicott, J. A. and Ling, V. (1989) The biochemistry of Pglycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58, 137-171
7. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427
8. Ford, J. M. and Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 156-199
9. Demeule, M., Jodoin, J., Gingras, D. and Beliveau, R. (2000) P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS. Lett. 466, 219-224
10. C is sorted to the basolateral membrane of epithelial cells independently of its association with rafts. Traffic 3, 810-821
11. Taraboulos, A., Scott, M., Semenov, A., Avrahami, D., Laszlo, L., and Prusiner, S. B. (1995) Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein Inhibit formation of the scrapie isoform. J. Cell Biol. 129, 121-132
12. Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E. and Gottesman, M. M. (2003) P-glycoprotein: From genomics to mechanism. Oncogene 22, 7468-7485
13. Zorzos, H., Lazaris, A., Korkolopoulou, P., Kavantzas, N., Tseleni-Balafouta, S., Patsouris, E., Tsavaris, N. and Davaris, P. (2003) Multidrug resistance proteins and topoisomerase-α expression in colon cancer: Association with metastatic potential. Pathology 35, 315-318
14. Pan, Y., Zhao, L., Liang, J., Liu, J., Shi, Y., Liu, N., Zhang, G., Jin, H., Gao, J., Xie, H., Wang, J., Liu, Z. and Fan, D. (2006) Cellular prion protein promotes invasion and metastasis of gastric cancer. FASEB. J. 20, 1886-1888
15. Du, J., Pan, Y., Shi, Y., Guo, C., Jin, X., Sun, L., Liu, N., Qiao, T. and Fan, D. (2005) Overexpression and significance of prion protein in gastric cancer and multidrug resistant gastric carcinoma cell line SGC7901/ADR. Int. J. Cancer 113, 213-220
16. Rittmann-Grauer, L. S., Yong, M. A., Sanders, V. and Mackensen, D. G. (1992) Reversal of vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody Hyb-241 in a human tumor xenograft. Cancer Res. 52, 1810-1816
17. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J. L., Lehmann, S., Launay, J. M. and Kellermann, O. (2000) Signal transduction through prion protein. Science 289, 1925-1928
18. Monnet, C., Gavard, J., Mege, R.-M. and Sobel, A. (2004) Clustering of cellular prion protein induces ERK1/2 and stathmin phosphorylation in GT1-7 neuronal cells. FEBS Lett. 576, 114-118
19. Pawlik, A., Baskiewicz-Masiuk, M., Machalinski, B. and Gawronska-Szklarz, B. (2005) Involvement of P-gp in the process of apoptosis in peripheral blood mononuclear cells. Int. Immunopharmacol. 5, 821-828
20. Gollapudi, S. and Gupta, S. (2001) Anti-P-glycoprotein antibody induced apoptosis of activated peripheral blood lymphocytes: Apossible role of P-glycoprotein in lymphocyte survival. J. Clin. Immunol. 21, 420-430
21. Ghetie, M. A., Marches, R., Kufert, S. and Vitetta, E. S. (2004) An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line. Blood 104, 178-183
22. Aziz, S. M., Worthen, D. R., Yatin, M., Ain, K. B. and Crooks, P. A. (1998) A unique interaction between polyamine and multidrug resistance (P-glycoprotein) transporters in cultured Chinese hamster ovary cells transfected with mouse mdr-1 gene. Biochem. Pharmacol. 56, 181-187
23. Yang, J.-M., Chin, K.-V. and Haiti, W. N. (1996) Interaction of P-glycoprotein with protein kinase C in human multidrug resistant carcinoma cells. Cancer Res. 56, 3490-3494
24. Miletti-Gonzalez, K. E., Chen, S., Muthukumaran, N., Saglimbeni, G. N., Wu, X., Yang, J., Apolito, K., Shih, W. J., Hait, W. N. and Rodriguez-Rodriguez, L. (2005) The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 65, 6660-6667
25. Triller, N., Korošec, P., Kern, I., Košnik, M. and Debeljak, A. (2006) Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer 54, 235-240
26. Wang, B., Li, X.-Q., Ma, X., Hong, X., Lu, H. and Guo, Y. (2008) Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am. J. Hematol. 83, 795-799
27. Pan, T., Wong, B. S, Liu, T., Li, R., Petersen, R. B. and Sy, M. S. (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem. J. 368, 81-90
28. Graner, E., Mercadante, A. F., Zanata, S. M., Forlenza, O. V., Cabral, A. L., Veiga, S. S., Juliano, M. A., Roesler, R., Walz, R., Minetti, A., Izquierdo, I., Martins, V.R. and Brentani, R. R. (2000) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res. Mol. Brain Res. 76, 85-92
29. Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., Crossin, K. L., Edelman, G. M., DeArmond, S. J., Cohen, F. E. and Prusiner, S. B. (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J. Mol. Biol. 314, 1209-1225
30. Shang, G. Y., Qiao, W. H., Lei, F. H., Angiboust, J. F., Troyon, M. and Manfait, M. (2005) Development of a shear force scanning near-field fluorescence microscope for biological applications. Ultramicroscopy 105, 324-329
31. Hundt, C., Gauczynski, S., Leucht, C., Riley, M. L. and Weiss, S. (2003) Intra- and interspecies interactions between prion proteins and effects of mutations and polymorphisms. Biol. Chem. 384, 791-803
32. Grande-Garcia, A. and Del Pozo, M. A. (2008) Caveolin-1 in cell polarization and directional migration. Eur. J. Cell Biol. 87, 641-647
33. Echarri, A., Muriel, O. and Del Pozo, M. A. (2007) Intracellular trafficking of raft/caveolae domains: Insights from integrin signaling. Semin. Cell Dev. Biol. 18, 627-637
34. Scherer, P. E, Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F and Lisanti, M. P. (1996) Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93, 131-135
35. Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T. and Thompson, T. C. (1998) Elevated expression of caveolin is associated with prostate and breast cancer. Clin. Cancer Res. 4, 1873-1880
36. Yang, G., Truong, L. D., Wheeler, T. M. and Thompson, T. C. (1999) Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res. 59, 5719-5723
37. Razani, B., Woodman, S. E. and Lisanti, M. P. (2002) Caveolae: From cell biology to animal physiology. Pharmacol. Rev. 54, 431-467
38. Robinson, L. J., Roberts, W. K., Ling, T. T., Lamming, D., Sternberg, S. S. and Roepe, P. D. (1997) Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36, 11169-11